News
Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), ...
The Marcus Corporation (NYSE: MCS) today reported results for the second quarter fiscal 2025 ended June 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback